Interestingly, both febuxostat and fingolimod treatments enhanced Nrf2 expression at the gene and protein levels, which might be significant in the context of reducing ROS burden, and their overall anti-inflammatory profile.
← all excerpts
Protein phosphatase 2A regulates xanthine oxidase-derived ROS production in macrophages and influx of inflammatory monocytes in a murine gout model.
1
—
—